CTOs on the Move

Cellenkos Incorporated

www.cellenkosinc.com

 
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Elizabeth Read
 Chief Technology Officer Profile

Funding

Cellenkos Incorporated raised $15M on 11/04/2021

Similar Companies

Critical Health Systems

Critical Health Systems is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Doe and Ingalls

Doe and Ingalls is a Medford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

First Health Group Corporation

First Health Group Corporation is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OccHealth Systems

OccHealth Systems is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wellmont Health System

Founded in 1996, Wellmont Health System is the premier healthcare provider in Northeast Tennessee and Southwest Virginia.